OOIR: Observatory of International Research

Papers

(The median citation count of Vaccines is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates	1156
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China	616
Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review	515
Factors Associated with COVID-19 Vaccine Hesitancy	427
High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries	423
COVID-19 Vaccine Acceptance among Health Care Workers in the United States	364
Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States	333
Nanomaterial Delivery Systems for mRNA Vaccines	295
COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries	281
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination	266
Lack of Trust, Conspiracy Beliefs, and Social Media Use Predict COVID-19 Vaccine Hesitancy	252
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines	216
Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials	209
Progress and Prospects on Vaccine Development against SARS-CoV-2	200
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19	198
Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries	197
Willingness to Receive COVID-19 Vaccination in Japan	188
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic	187
Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys	185
Vaccine Knowledge, Awareness and Hesitancy: A Cross Sectional Survey among Parents Residing at Sandakan District, Sabah	171
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond	164
Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines	145
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm	141
Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects	133
Relationship between Citizens’ Health Engagement and Intention to Take the COVID-19 Vaccine in Italy: A Mediation Analysis	124

A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants	124
Human Papillomavirus Vaccines: An Updated Review	123
Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations	120
The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study	118
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland	111
Addressing Parental Vaccine Hesitancy towards Childhood Vaccines in the United States: A Systematic Literature Review of Communication Interventions and Strategies	111
An Update on Self-Amplifying mRNA Vaccine Development	109
Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study	109
COVID-19 Vaccine Hesitancy and Its Associated Factors in Japan	109
Post-COVID Syndrome: An Insight on Its Pathogenesis	108
Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy	107
Recent Progress on the Versatility of Virus-Like Particles	105
Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis	105
COVID-19 Vaccine Roll-Out in South Africa and Zimbabwe: Urgent Need to Address Community Preparedness, Fears and Hesitancy	104
Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors	104
Socioeconomic Determinants in Vaccine Hesitancy and Vaccine Refusal in Italy	102
Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers: A Cross-Sectional Study from Poland	102
Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy	100
Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans	100
Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination	99
The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review	97
Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia	97
Medical Students and SARS-CoV-2 Vaccination: Attitude and Behaviors	95
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection	95
COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey	94
Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery	94
Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales	93
COVID-19 Vaccine Hesitancy and Resistance in India Explored through a Population-Based Longitudinal Survey	93
The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation	93
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants	92
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers	91
Comparison of Four SARS-CoV-2 Neutralization Assays	91
Flattening the Curve of COVID-19 Vaccine Rejection—An International Overview	91
Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication	89
COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis	89
Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection	88
COVID-19 Vaccine Hesitancy and Attitude toward Booster Doses among US Healthcare Workers	88
Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3	88
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy	87
Relationship between Influenza Vaccination Coverage Rate and COVID-19 Outbreak: An Italian Ecological Study	87
COVID-19 Vaccination Hesitancy among Healthcare Workers—A Review	86
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2	86
Acceptability of COVID-19 Vaccination among Greek Health Professionals	86
Efforts at COVID-19 Vaccine Development: Challenges and Successes	85
Examining Vaccine Hesitancy in Sub-Saharan Africa: A Survey of the Knowledge and Attitudes among Adults to Receive COVID-19 Vaccines in Ghana	85
Vaccine Hesitancy on Social Media: Sentiment Analysis from June 2011 to April 2019	85
The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland	85
Acceptability of a COVID-19 Vaccine among the Saudi Population	84
Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines	84
Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany	84

Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines	82
Motivation to Have COVID-19 Vaccination Explained Using an Extended Protection Motivation Theory among University Students in China: The Role of Information Sources	82
COVID-19 Vaccine Acceptance, Hesitancy, and Resistancy among University Students in France	81
Knowledge and Acceptance of COVID-19 Vaccination among Undergraduate Students from Central and Southern Italy	81
Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic	81
Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey	80
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times	79
COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study	78
Global Prevalence and Drivers of Dental Students’ COVID-19 Vaccine Hesitancy	77
COVID-19: Mechanisms of Vaccination and Immunity	76
Factors Influencing Public Attitudes towards COVID-19 Vaccination: A Scoping Review Informed by the Socio-Ecological Model	76
Current State of Global African Swine Fever Vaccine Development under the Prevalence and Transmission of ASF in China	76
Hesitancy of Arab Healthcare Workers towards COVID-19 Vaccination: A Large-Scale Multinational Study	76
Current Status of Zika Virus Vaccines: Successes and Challenges	75
COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study	75
Intention to Receive the COVID-19 Vaccination in China: Application of the Diffusion of Innovations Theory and the Moderating Role of Openness to Experience	74
Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports	74
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer	74
A COVID-19 Vaccine: Big Strides Come with Big Challenges	73
mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice	72
COVID-19 Vaccine Hesitancy among French People Living with HIV	72
Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses	72
Hesitant or Not Hesitant? A Systematic Review on Global COVID-19 Vaccine Acceptance in Different Populations	72
Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis	71
Impact of COVID-19 Pandemic on Flu and COVID-19 Vaccination Intentions among University Students	71
Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity	71
Effect of Information about COVID-19 Vaccine Effectiveness and Side Effects on Behavioural Intentions: Two Online Experiments	70
Determinants of COVID-19 Vaccine Acceptance among the Adult Population of Bangladesh Using the Health Belief Model and the Theory of Planned Behavior Model	70
What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?	69
Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes	69
Knowledge, Attitudes and Perceptions of COVID-19 Vaccination among Healthcare Workers of an Inner-City Hospital in New York	68
Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge	67
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand	67
COVID-19 Vaccine Hesitancy among Parents of Children and Adolescents Living in Brazil	67
Factors Affecting Attitudes towards COVID-19 Vaccination: An Online Survey in Slovenia	66
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics	66
Social Patterning and Stability of Intention to Accept a COVID-19 Vaccine in Scotland: Will Those Most at Risk Accept a Vaccine?	65
A Rapid Systematic Review of Factors Influencing COVID-19 Vaccination Uptake in Minority Ethnic Groups in the UK	65
Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy	65
Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China—A Cross-Sectional Study	65
Pruritus as a Distinctive Feature of Type 2 Inflammation	64
Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections	64
The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey	64
Prevalence and Drivers of COVID-19 Vaccine Hesitancy among Czech University Students: National Cross-Sectional Study	64
Willingness of Taiwan’s Healthcare Workers and Outpatients to Vaccinate against COVID-19 during a Period without Community Outbreaks	64
mRNA-Based Vaccines	63
Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis	63
Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis	63
Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database	63
DC-Based Vaccines for Cancer Immunotherapy	63
Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis	63
Impact of COVID-19 on Immunization Services for Maternal and Infant Vaccines: Results of a Survey Conducted by Imprint—The Immunising Pregnant Women and Infants Network	63
Knowledge, Attitudes, and Practices (KAP) toward the COVID-19 Vaccine in Oman: A Pre-Campaign Cross-Sectional Study	63
Reasons for Taking the COVID-19 Vaccine by US Social Media Users	62
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective	62
Healthcare Providers’ Vaccine Perceptions, Hesitancy, and Recommendation to Patients: A Systematic Review	62
A Pool of Eight Virally Vectored African Swine Fever Antigens Protect Pigs against Fatal Disease	62
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment	61
Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine	61
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination	60
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines	60
Knowledge and Attitude towards Vaccination among Healthcare Workers: A Multicenter Cross-Sectional Study in a Southern Italian Region	59
Review: Vaccines and Vaccination against Lumpy Skin Disease	59
Fear of COVID-19 and Perceived COVID-19 Infectability Supplement Theory of Planned Behavior to Explain Iranians’ Intention to Get COVID-19 Vaccinated	59
Attitudes of Patients with Cancer towards Vaccinations—Results of Online Survey with Special Focus on the Vaccination against COVID-19	59
The COVID-19 Vaccines: Recent Development, Challenges and Prospects	58
Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine	58
COVID-19 Vaccination Acceptance and Hesitancy among Healthcare Workers in Germany	58
Investigating the Influence of Vaccine Literacy, Vaccine Perception and Vaccine Hesitancy on Israeli Parents’ Acceptance of the COVID-19 Vaccine for Their Children: A Cross-Sectional Study	57
Generation and Evaluation of an African Swine Fever Virus Mutant with Deletion of the CD2v and UK Genes	57
Selecting Target Antigens for Cancer Vaccine Development	57
Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients	57
Natural and Synthetic Saponins as Vaccine Adjuvants	57
A Comparison of the Level of Acceptance and Hesitancy towards the Influenza Vaccine and the Forthcoming COVID-19 Vaccine in the Medical Community	57
The Effectiveness of Interventions for Increasing COVID-19 Vaccine Uptake: A Systematic Review	56
Parents’ and Guardians’ Willingness to Vaccinate Their Children against COVID-19: A Systematic Review and Meta-Analysis	56
Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study	56
Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study	56
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives	56
Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism	56

Current State of the First COVID-19 Vaccines	55
The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID	55
The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review	55
GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines	55
The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines	54
COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly	54
Global Trends and Correlates of COVID-19 Vaccination Hesitancy: Findings from the iCARE Study	54
Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis	54
Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy	53
Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach	53
Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach	53
Targeting Innate Immunity in Cancer Therapy	53
COVID-19 Vaccination Willingness among Chinese Adults under the Free Vaccination Policy	52
Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines	52
Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients–A Single-Center Experience	51
Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine	51
#Scamdemic, #Plandemic, or #Scaredemic: What Parler Social Media Platform Tells Us about COVID-19 Vaccine	51
Measurement Invariance of the Drivers of COVID-19 Vaccination Acceptance Scale: Comparison between Taiwanese and Mainland Chinese-Speaking Populations	51
COVID-19 Vaccine Donations—Vaccine Empathy or Vaccine Diplomacy? A Narrative Literature Review	51
Global Predictors of COVID-19 Vaccine Hesitancy: A Systematic Review	50
Acceptance of COVID-19 Vaccine among the Healthcare Workers in the Eastern Cape, South Africa: A Cross Sectional Study	50
The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies	50
Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States	50
The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19	50
Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer’s Disease (AD); Underwhelming Evidence against	50
Development of mRNA Vaccines: Scientific and Regulatory Issues	50
COVID-19 Vaccine Acceptability and Its Determinants in Mozambique: An Online Survey	49
Acceptance of COVID-19 Vaccination among Front-Line Health Care Workers: A Nationwide Survey of Emergency Medical Services Personnel from Germany	49
Role of Physiology, Immunity, Microbiota, and Infectious Diseases in the Gut Health of Poultry	49
Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients	49
The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination—An Analysis of Serological Response and Side Effects	49
Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	49
In Silico Prediction of a Multitope Vaccine against Moraxella catarrhalis: Reverse Vaccinology and Immunoinformatics	49
Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets	49
Disparities in COVID-19 Vaccination among Low-, Middle-, and High-Income Countries: The Mediating Role of Vaccination Policy	49
Correlates of Vaccine-Induced Protection against SARS-CoV-2	49
The Health Belief Model Predicts Intention to Receive the COVID-19 Vaccine in Saudi Arabia: Results from a Cross-Sectional Survey	49
Association between Exposure to Influenza Vaccination and COVID-19 Diagnosis and Outcomes	48
BNT162b2 COVID-19 Vaccine Hesitancy among Parents of 4023 Young Adolescents (12–15 Years) in Qatar	48
Exploring the Willingness to Accept SARS-CoV-2 Vaccine in a University Population in Southern Italy, September to November 2020	48
Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats	48
An Overview of Influenza Viruses and Vaccines	48
Anti-Tick Microbiota Vaccine Impacts Ixodes ricinus Performance during Feeding	48
Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing	47
Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2	47
Commercial PRRS Modified-Live Virus Vaccines	47
The Age of Cyclic Dinucleotide Vaccine Adjuvants	47
Trusted Sources of COVID-19 Vaccine Information among Hesitant Adopters in the United States	47
Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers	47
A Rapid Systematic Review of Public Responses to Health Messages Encouraging Vaccination against Infectious Diseases in a Pandemic or Epidemic	47
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines	47
COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study	47
Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma	47
Impact of the COVID-19 Pandemic on Routine Childhood Immunization in Saudi Arabia	47
Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective	47
Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers	47
Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis	47
Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines	46
Porcine Reproductive and Respiratory Syndrome Modified Live Virus Vaccine: A “Leaky” Vaccine with Debatable Efficacy and Safety	46
The Association between Influenza Vaccination and COVID-19 and Its Outcomes: A Systematic Review and Meta-Analysis of Observational Studies	46
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities	46
COVID-19 Vaccination Intent and Willingness to Pay in Bangladesh: A Cross-Sectional Study	46
A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues	46
Spain’s Hesitation at the Gates of a COVID-19 Vaccine	46
Evaluating COVID-19 Vaccine Willingness and Hesitancy among Parents of Children Aged 5–11 Years with Chronic Conditions in Italy	46
SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines	46
Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya	46
Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise	46
Vaccines against Coronaviruses: The State of the Art	46
Neo-Antigen mRNA Vaccines	45
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine	45
Coccidiosis: Recent Progress in Host Immunity and Alternatives to Antibiotic Strategies	45
COVID-19 Vaccine Acceptability and Adherence to Preventive Measures in Somalia: Results of an Online Survey	45
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination	45
IMVAMUNE® and ACAM2000® Provide Different Protection against Disease When Administered Postexposure in an Intranasal Monkeypox Challenge Prairie Dog Model	45
Predictors of Willingness to Receive COVID-19 Vaccine: Cross-Sectional Study of Palestinian Dental Students	45
Correlates of COVID-19 Vaccine Hesitancy among a Community Sample of African Americans Living in the Southern United States	45
A Comparison of Vaccine Hesitancy of COVID-19 Vaccination in China and the United States	44
COVID-19 Vaccine Hesitancy in Poland—Multifactorial Impact Trajectories	44
A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?	44
Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery	44
Vaccine Hesitancy: Contemporary Issues and Historical Background	44
Vaccinations and Autoimmune Diseases	44
Challenges and Opportunities of Mass Vaccination Centers in COVID-19 Times: A Rapid Review of Literature	44
The COVID-19 Vaccine Is Here—Now Who Is Willing to Get It?	44
Plant-Derived Nutraceuticals and Immune System Modulation: An Evidence-Based Overview	43
Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects	43
Effect of COVID-19 Pandemic on Influenza Vaccination Intention: A Meta-Analysis and Systematic Review	43
Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19	43
Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy	43
Prevalence and Potential Determinants of COVID-19 Vaccine Hesitancy and Resistance in Qatar: Results from a Nationally Representative Survey of Qatari Nationals and Migrants between December 2020 and	43
Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages—Potential Implications for Cytokine Storm Syndrome	43
Nanoparticle-Based Delivery Systems for Vaccines	42
COVID-19 Pandemic and Equal Access to Vaccines	42
COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response	42